Cogstate CEO and MD Brad O’Connor talked with Proactive at the ASX Small and Mid-Cap Conference about its central nervous system trials, its defining FY26 and what’s to come in FY27. Cogstate Ltd (ASX ...

BOSTON--(BUSINESS WIRE)--The cognitive science company, Cogstate, today announced that its Healthcare Division has received CE Mark approval for its Cognigram TM digital cognitive assessment system.

Japanese pharma Eisai is boosting its 2019 pact with Australian medtech firm Cogstate and its cognitive function test. The original pact, penned last August, was a development and sales deal centered ...

Melbourne, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today the appointment of Chris Edgar, PhD as Chief Science Officer and Prof. Paul Maruff ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--The cognitive science company, Cogstate Ltd (ASX:CGS) today announced it has been chosen as the preferred provider to the global healthcare leader, Eli Lilly and ...

Cogstate, Nufarm and Ramelius Resources are drawing ASX attention as healthcare technology, agricultural operations and gold production developments shape their latest market narratives.

Biopharma sponsors and CROs now have access to a modern eCOA solution that seamlessly integrates a configurable, no-code platform with validated cognitive assessments and deep clinical expertise ...

Dementia is Australia’s leading cause of death. ASX healthcare companies are among those searching for better ways to detect ...

Detailed price information for Cogstate Ltd Ord (COGZF) from The Globe and Mail including charting and trades.